Markets › India › NSE › SUVEN

Suven Life Sciences Ltd

NSE:SUVENHealthcareNSE:NIFTY_MICROCAP250NSE:NIFTY_TOTAL_MKT

₹290.05−4.45%At closeAt close · Mon 19 Oct · ≈ AED 11.19 · Market cap $901.7M

Ratio	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026	Current · undated	YoY
Gross margin	99.2%	−115.9%	95.8%	92.9%	−415.2%	−589.3%	—	—
Operating margin	−622.3%	−1,065.6%	−974.3%	−1,048.3%	−2,578.1%	−4,077.7%	−4,077.7%	+0.0 pts
Net margin	−535.3%	−1,030.0%	−873.5%	−898.6%	−2,415.1%	−3,884.1%	−3,884.1%	+0.0 pts
EBITDA margin	−535.6%	−987.3%	−822.2%	−849.0%	−2,326.9%	−3,803.0%	—	—
Return on equity	−66.8%	−126.9%	−31.5%	−38.9%	−146.1%	−46.7%	−46.7%	+0.0 pts
Return on assets	−56.2%	−112.9%	−30.4%	−36.9%	−118.9%	−44.3%	−44.3%	+0.0 pts
Return on capital employed	−74.5%	−126.6%	−34.9%	−45.2%	−153.6%	−48.9%	—	—
Debt / equity	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	+0.0%
Debt / assets	3.7%	3.0%	0.4%	0.2%	0.0%	2.7%	—	—
Interest coverage	−89.2×	−188.9×	−320.3×	−410.7×	−3,682.3×	−1,838.5×	—	—
Current ratio	6.5×	8.0×	22.6×	19.0×	3.2×	17.7×	17.7×	+0.0%
Quick ratio	6.4×	8.0×	22.6×	18.9×	3.2×	17.7×	—	—
Cash ratio	0.6×	0.6×	3.3×	1.1×	1.6×	10.9×	10.9×	+0.0%
Asset turnover	0.1×	0.1×	0.0×	0.0×	0.0×	0.0×	—	—
Inventory turnover	0.2×	775.0×	71.6×	1.2×	144.4×	480.8×	—	—
Receivables turnover	0.3×	5.8×	1.0×	3.4×	4.7×	4.7×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—

Margins, returns, leverage and liquidityUpdated Tue 31 Mar ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.